Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: A subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial

American Heart Journal

Volumn 168, Issue 3, 2014, Pages 303-309

  Goto, Shinya ^a   Zhu, Jun ^b   Liu, Lisheng ^c   Oh, Byung Hee ^d   Wojdyla, Daniel M ^e   Aylward, Philip ^f   Bahit, M Cecilia ^g   Gersh, Bernard J ^h   Hanna, Michael ⁱ   Horowitz, John ^j   Lopes, Renato D ^e   Wallentin, Lars ^k   Xavier, Denis ^l   Alexander, John H ^e  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUWAI HOSPITAL   (China)

^c State Key Laboratory of Cardiovascular Disease Department of Pathology National Center for Cardiovascular Disease   (China)

^d Seoul National University Hospital   (South Korea)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f FLINDERS UNIVERSITY   (Australia)

^g Grupo Oroño   (Argentina)

^h MAYO CLINIC   (United States)

ⁱ BRISTOL MYERS SQUIBB   (United States)

^j QUEEN ELIZABETH HOSPITAL   (Australia)

^k UPPSALA UNIVERSITY   (Sweden)

^l ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FAR EAST; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRAZOLES; PYRIDONES; STROKE; WARFARIN;

EID: 84908545649     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.06.005     Document Type: Article

References (15)